Gül Erdemli

2.6k total citations
39 papers, 1.7k citations indexed

About

Gül Erdemli is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Gül Erdemli has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 25 papers in Cellular and Molecular Neuroscience and 9 papers in Cognitive Neuroscience. Recurrent topics in Gül Erdemli's work include Neuroscience and Neuropharmacology Research (22 papers), Ion channel regulation and function (20 papers) and Neuroscience and Neural Engineering (8 papers). Gül Erdemli is often cited by papers focused on Neuroscience and Neuropharmacology Research (22 papers), Ion channel regulation and function (20 papers) and Neuroscience and Neural Engineering (8 papers). Gül Erdemli collaborates with scholars based in United Kingdom, Canada and United States. Gül Erdemli's co-authors include Dimitri M. Kullmann, Fredrik Asztély, Ole H. Petersen, K. Krnjević, Jeremy Ward, John P. Neoptolemos, Camille Vaillant, Michael Raraty, Robert Sutton and Vincenzo Crunelli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuron and Journal of Neuroscience.

In The Last Decade

Gül Erdemli

39 papers receiving 1.6k citations

Peers

Gül Erdemli
E. Ongini Italy
Melanie J. Robbins United Kingdom
Ana Dı́ez-Sampedro United States
Subbu Apparsundaram United States
Sandra Lechner United States
E. Ongini Italy
Gül Erdemli
Citations per year, relative to Gül Erdemli Gül Erdemli (= 1×) peers E. Ongini

Countries citing papers authored by Gül Erdemli

Since Specialization
Citations

This map shows the geographic impact of Gül Erdemli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gül Erdemli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gül Erdemli more than expected).

Fields of papers citing papers by Gül Erdemli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gül Erdemli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gül Erdemli. The network helps show where Gül Erdemli may publish in the future.

Co-authorship network of co-authors of Gül Erdemli

This figure shows the co-authorship network connecting the top 25 collaborators of Gül Erdemli. A scholar is included among the top collaborators of Gül Erdemli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gül Erdemli. Gül Erdemli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erdemli, Gül, et al.. (2025). Regulatory considerations for successful implementation of digital endpoints in clinical trials for drug development. npj Digital Medicine. 8(1). 142–142. 2 indexed citations
2.
Brem, Anna‐Katharine, Casper de Boer, Ana Diaz‐Ponce, et al.. (2023). Digital endpoints in clinical trials of Alzheimer’s disease and other neurodegenerative diseases: challenges and opportunities. Frontiers in Neurology. 14. 1210974–1210974. 14 indexed citations
3.
Boer, Casper de, Jelena Curcic, Vera J. M. Nies, et al.. (2021). Gait characteristics in preclinical Alzheimer’s disease: Preliminary results of the RADAR‐AD study. Alzheimer s & Dementia. 17(S5). 2 indexed citations
4.
Wickenden, Alan, Birgit T. Priest, & Gül Erdemli. (2012). Ion Channel Drug Discovery: Challenges And Future Directions. Future Medicinal Chemistry. 4(5). 661–679. 45 indexed citations
5.
Williams, Sarah, et al.. (2012). The translocation kinetics of antibiotics through porin OmpC: Insights from structure‐based solvation mapping using WaterMap. Proteins Structure Function and Bioinformatics. 81(2). 291–299. 36 indexed citations
6.
Li, Nianzhen, Qin Chen, Tong Lee, et al.. (2011). IonFlux: A Microfluidic Patch Clamp System Evaluated with Human Ether-à-go-go Related Gene Channel Physiology and Pharmacology. Assay and Drug Development Technologies. 9(6). 608–619. 31 indexed citations
7.
Bursi, Roberta, Gül Erdemli, Robert A. Campbell, et al.. (2011). Translational PK–PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576. Psychopharmacology. 218(4). 713–724. 13 indexed citations
8.
Cao, Xueying, Mats Holmqvist, Yingxin Lin, et al.. (2010). Cardiac Ion Channel Safety Profiling on the IonWorks Quattro Automated Patch Clamp System. Assay and Drug Development Technologies. 8(6). 766–780. 14 indexed citations
9.
Voronina, Svetlana, et al.. (2002). Correlation of NADH and Ca2+ signals in mouse pancreatic acinar cells. The Journal of Physiology. 539(1). 41–52. 90 indexed citations
10.
Johnson, Paul, Alexei V. Tepikin, & Gül Erdemli. (2002). Role of mitochondria in Ca2+ homeostasis of mouse pancreatic acinar cells. Cell Calcium. 32(2). 59–69. 25 indexed citations
11.
Erdemli, Gül & Vincenzo Crunelli. (2000). Release of monoamines and nitric oxide is involved in the modulation of hyperpolarization-activated inward current during acute thalamic hypoxia. Neuroscience. 96(3). 565–574. 8 indexed citations
12.
Demirci, Mehmet, Cenk Ayata, Turgay Dalkara, Gül Erdemli, & R. Onur. (1997). Monitoring cellular edema at single-neuron level by electrical resistance measurements. Journal of Neuroscience Methods. 72(2). 175–181. 10 indexed citations
13.
Asztély, Fredrik, Gül Erdemli, & Dimitri M. Kullmann. (1997). Extrasynaptic Glutamate Spillover in the Hippocampus: Dependence on Temperature and the Role of Active Glutamate Uptake. Neuron. 18(2). 281–293. 356 indexed citations
14.
Kullmann, Dimitri M., Gül Erdemli, & Fredrik Asztély. (1996). LTP of AMPA and NMDA Receptor–Mediated Signals: Evidence for Presynaptic Expression and Extrasynaptic Glutamate Spill-Over. Neuron. 17(3). 461–474. 236 indexed citations
15.
Erdemli, Gül & K. Krnjević. (1996). Tolbutamide blocks Ca2+- and voltage-dependent K+ currents of hippocampal Ca1 neurons. European Journal of Pharmacology. 304(1-3). 37–47. 14 indexed citations
16.
Erdemli, Gül, et al.. (1996). Is activation of metabotropic glutamate receptors responsible for acute hypoxic changes in hippocampal neurons?. Brain Research. 723(1-2). 1–7. 2 indexed citations
17.
Erdemli, Gül & K. Krnjević. (1994). Actions of cromakalim on outward currents of CA1 neurones in hippocampal slices. British Journal of Pharmacology. 113(2). 411–418. 6 indexed citations
18.
Erdemli, Gül & K. Krnjević. (1993). Diazoxide suppresses slowly-inactivating outward and inward currents in CA1 hippocampal neurones. Neuroreport. 5(3). 249–251. 8 indexed citations
19.
Dalkara, Turgay, et al.. (1992). Glycine is required for NMDA receptor activation: electrophysiological evidence from intact rat hippocampus. Brain Research. 576(2). 197–202. 30 indexed citations
20.
Dalkara, Turgay, et al.. (1990). Electrophysiological evidence for activation of NMDA receptors and its antagonism by MK-801 in cerebral ischemia. Brain Research. 532(1-2). 101–106. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026